Skip to main content

Day: April 1, 2022

Starfleet Innotech Launches Digital Ads on Nasdaq Building and across Times Square, New York City

“We’re thrilled to be telling this story through our placements at Times Square, signaling to our team, our business ecosystem, and our community that Starfleet is blasting off.” NEW YORK, April 01, 2022 (GLOBE NEWSWIRE) — Starfleet Innotech, Inc. (OTC Pink: SFIO) (“SFIO” or “The “Company”) this week launched a digital campaign promoting the company and its projects through electronic billboard placements on the Nasdaq Building and on select street-level screens across Times Square in New York City. These digital placements complement SFIO’s ongoing expansion plans, in collaboration with media partner FMW Media. The 15 and 30-second ads highlight the conglomerate’s core divisions, key businesses, and growth roadmap. Starfleet Innotech, Inc. is a global investment holding company focused on innovation through...

Continue reading

Costamare Inc. Declares Special and Quarterly Dividend on its Common Stock and Quarterly Dividend on its Preferred Stock

MONACO, April 01, 2022 (GLOBE NEWSWIRE) — Costamare Inc. (the “Company”) (NYSE: CMRE) has declared cash dividends of US $0.476563 per share on its 7.625% Series B Cumulative Redeemable Perpetual Preferred Stock (the “Series B Preferred Stock”) (NYSE: CMRE PR B), US $0.531250 per share on its 8.50% Series C Cumulative Redeemable Perpetual Preferred Stock (the “Series C Preferred Stock”) (NYSE: CMRE PR C), US $0.546875 per share on its 8.75% Series D Cumulative Redeemable Perpetual Preferred Stock (the “Series D Preferred Stock”) (NYSE: CMRE PR D) and US $0.554688 per share on its 8.875% Series E Cumulative Redeemable Perpetual Preferred Stock (the “Series E Preferred Stock”) (NYSE: CMRE PR E). The dividend for the Series B Preferred Stock, the Series C Preferred Stock, the Series D Preferred Stock and the Series E Preferred Stock...

Continue reading

La Mancha Announces Acquisition of Shares of Elemental Royalties Corp.

LONDON, April 01, 2022 (GLOBE NEWSWIRE) — La Mancha Fund SCSp (the “Fund”), a fund advised by La Mancha Capital Advisory LLP (“La Mancha”), is pleased to announce that its wholly-owned subsidiary, La Mancha Investments S.à r.l. (“LMI”), yesterday acquired 7,250,000 common shares (the “Shares”) of Elemental Royalties Corp. (“Elemental”) (TSX-V: ELE, OTCQX: ELEMF) at a subscription price of C$1.51 per Share for an aggregate subscription price of approximately US$8.5 million. The net proceeds of the subscription will be used by Elemental to fund its acquisition of the Ming Gold stream. The Fund owns 7,250,000 common shares of Elemental following completion of the subscription, representing approximately 9.3% of Elemental’s issued and outstanding common shares. The Fund completed the subscription and acquired the Shares for business...

Continue reading

Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2021

June 2021 Acquisition of Viactiv® Brand and Business Changed Operational Focus of Company and Materially Impacted 2021 Revenues, Operations and Financial Results Viactiv® Generated Net Revenues of approximately $2.4 Million or 92% of Net Revenues for the Quarter Ended December 31, 2021, and approximately $6.5 Million or 90% of Net Revenues for the Year Ended December 31, 2021 HOUSTON, April 01, 2022 (GLOBE NEWSWIRE) — Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that develops clinically supported nutrition, medical foods, and dietary supplements, announced its financial results for the year ended December 31, 2021. The Company also provided a corporate update to shareholders. The financial highlights presented below were impacted by the Company’s acquisition, effective...

Continue reading

Endexx Announces Fiscal 2021 Year-End Audited Financial Results

Endexx Q4 Sales Rebounded Increasing 360% Above Q3 Revenues CAVE CREEK, AZ, April 01, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Endexx Corporation (OTC: EDXC), a provider of innovative Hemp-derived wellness and nutritional products, today announced its audited fiscal 2021 annual report.  Endexx faced multiple challenges associated with the Pandemic and a slowdown in the retail markets during the first three quarters of its fiscal 2021. Ongoing supply chain issues impacted packaging and individual ingredient availability delaying production runs in key product sets during the fiscal year.  Consumer foot-traffic declines and retail store closings affected the revenue growth curve in 2021. Endexx reported its first revenue pullback since entering the Hemp Industry in 2014. The company had a 43% reduction in top line revenue in fiscal...

Continue reading

BioCorRx Provides 2021 Year-End Business Update

ANAHEIM, CA, April 01, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and related disorders, today provided a year-end business update for 2021 and reported on recent corporate developments. Lourdes Felix, CEO, CFO and Director of BioCorRx Inc., commented, “In 2021, we achieved a number of important milestones and accomplishments. During the second quarter of 2021, we received clearance from the U.S. Food and Drug Administration (FDA) to proceed to human trials for BICX104, a gradual release implantable pellet for opioid use disorder (OUD) being developed under the Company’s controlled subsidiary, BioCorRx Pharmaceuticals, Inc. BICX104 is being developed with the goal of improving patient compliance to naltrexone...

Continue reading

Healthy Extracts Reports Fourth Quarter and Full Year 2021 Results

LAS VEGAS, April 01, 2022 (GLOBE NEWSWIRE) — Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator of clinically proven plant-based products for heart and brain health, reported results for the fourth quarter and full year ended December 31, 2021. Q4 Financial HighlightsNet revenue totaled $672,000, up 77% sequentially and up 394% from the same year-ago quarter. Net income of $535,000, improving from a net loss of $1.6 million in the same year-ago quarter.Full Year 2021 Financial HighlightsNet revenue increased 15% to record $1.5 million. Gross profit was $695,000 or 47.4% of net revenue. Operating expenses reduced by $471,000 to $2.6 million.2021 Operational HighlightsIntroduced breakthrough nutraceutical formulation, Ultimate Brain Nutrients™ (UBN™) ACTIVATE™, clinically shown to increase key brain activity by as...

Continue reading

Brain Scientific Announces Fourth Quarter and Full Year 2021 Results

LAKEWOOD Ranch, Fla., April 01, 2022 (GLOBE NEWSWIRE) — via InvestorWire – Brain Scientific (OTCQB: BRSF), an innovative company focusing on the Medical Technology market, reports its business highlights and financial results for the fourth quarter and full year ended Dec. 31, 2021. Fourth Quarter and Recent HighlightsCompleted merger with Piezo Motion and announced Hassan Kotob as CEO of the combined company Appointed new independent directors Daniel Cloutier, Thomas Olivier, and Donald MacKenzie as to the Brain Scientific board Appointed two senior executives to lead revenue generation efforts Announced global partnership with a global master agent, advancing innovative neurodiagnostic devices Partnered with Benson Engineering to deliver affordable micro-precision motors and motion control solutions to the southern U.S. Hosted...

Continue reading

Smart for Life Announces FY 2021 Financial Results

Company Achieves 360% Increase in Revenue in 2021 through Implementation of Successful Acquisition Strategy Completed Three Material Acquisitions in Last Six Months of the Year Currently Operating at a $20 Million Revenue Run Rate MIAMI, April 01, 2022 (GLOBE NEWSWIRE) — Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a global leading developer, marketer, and manufacturer of nutritional and related products, today announced financial results and provided a business update for the year ended December 31, 2021. “2021 was a transformational year for the Company as revenue increased more than four-fold mainly as the result of acquisitions that closed in 2021, in addition to significantly expanding our product lines, production capabilities, distribution and marketing capabilities,” stated A.J. Cervantes, Jr.,...

Continue reading

1847 Holdings Announces Fiscal Year 2021 Financial Results with Proforma Revenue Up 23.5% to $51.5M

NEW YORK, April 01, 2022 (GLOBE NEWSWIRE) — 1847 Holdings LLC (OTCQB: EFSH) (“1847 Holdings”), a publicly traded holding company platform that combines the attractive attributes of private, lower-middle market businesses with the liquidity and transparency of a publicly traded company, today announced financial results for its fiscal year ended December 31, 2021. 2021 HighlightsGenerated proforma revenue of $51.5 million for the year ended December 31, 2021, up from proforma revenue of $41.7 million in 2020. Completed acquisitions of Wolo, High Mountain, and Innovative Cabinets Declared first quarterly dividend in December 2021 Secured $24.86 million institutional funding at the holding company level Appointed finance and accounting veteran Vernice Howard as CFO and leading lean manufacturing executive Eric VanDam as COO“I...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.